Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum

In December 2008, the U.S. Food and Drug Administration issued guidance to the pharmaceutical industry setting new expectations for the development of antidiabetes drugs for type 2 diabetes. This guidance expanded the scope and cost of research necessary for approval of such drugs by mandating long-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Care
Hauptverfasser: Cefalu, William T., Kaul, Sanjay, Gerstein, Hertzel C., Holman, Rury R., Zinman, Bernard, Skyler, Jay S., Green, Jennifer B., Buse, John B., Inzucchi, Silvio E., Leiter, Lawrence A., Raz, Itamar, Rosenstock, Julio, Riddle, Matthew C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Diabetes Association 2018
Schlagworte:
Diabetes Care Expert Forum
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741160/
https://ncbi.nlm.nih.gov/pubmed/29263194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dci17-0057
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge